CareDx Inc. revises revenue guidance for the full year ended December 31, 2023. For the period, the company expects revenue to be in the range of $279 million to $280 million, which is above the high end of guidance for fiscal year 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.39 USD | +2.35% | +6.28% | +19.92% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.92% | 734M | |
-43.30% | 8.28B | |
+7.54% | 3.62B | |
+0.37% | 2.24B | |
-24.94% | 1.94B | |
-16.61% | 1.72B | |
+7.94% | 962M | |
-11.57% | 690M | |
-32.86% | 477M | |
+4.37% | 298M |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- CareDx, Inc Revises Revenue Guidance for the Full Year Ended December 31, 2023